-
Shanthikumar, S, Ranganathan, S, Neeland, MR.
Ivacaftor, not ivacaftor/lumacaftor, associated with lower pulmonary inflammation in preschool cystic fibrosis..
Pediatr Pulmonol
57(10)
:
2549 -2552
2022
view publication
-
Kim, S, Collins, G, Giraldo, DM, Giacalone, V, Shanthikumar, S, Rao, P, Ranganathan, S, Stick, S, Tirouvanziam, R, Chandler, J.
386 Association between myeloperoxidase activity and methionine oxidation products in bronchoalveolar lavage and risk of bronchiectasis in infants and toddlers with cystic fibrosis.
Journal of Cystic Fibrosis
21:
s226
2022
view publication
-
Giraldo, DM, Giacalone, V, Shanthikumar, S, Ranganathan, S, Rao, P, Stick, S, Chandler, J, Esther, C, Tirouvanziam, R.
414 Longitudinal analysis of early-life bronchoalveolar fluid identifies immune mediators associated with bronchiectasis risk in children with cystic fibrosis.
Journal of Cystic Fibrosis
21:
s240
2022
view publication
-
Shanthikumar, S, Kim, S, Giacalone, V, Rao, P, Ranganathan, S, Karpievitch, Y, Stick, S, Boucher, R, Tirouvanziam, R, Chandler, J, et al.
446 Metabolites in early life bronchoalveolar fluid associate with future bronchiectasis risk in children with cystic fibrosis.
Journal of Cystic Fibrosis
21:
s256
2022
view publication
-
Shanthikumar, S, Maksimovic, J, Oshlack, A, Ranganathan, S, Neeland, M.
A multimodal cell atlas of the pediatric lower airway.
4411
2022
view publication